Navigation Links
CMPMedica Expands with Multiple Additional Vertical Search Applications co-developed with Convera(R)

VIENNA, Va., March 24 /PRNewswire-FirstCall/ -- CMPMedica has expanded to include a number of additional vertical search applications for specialist medical conditions. was co- developed with Convera Corporation (Nasdaq: CNVR), , a leading provider of vertical search services for publishers.

(Logo: ) has been serving primary health care professionals in North America, the UK, France and Spain, and Psychiatry and Oncology specialists in North America. Since its launch in late 2006, the popularity of the service has risen dramatically and today generates millions of queries per month.

"We are delighted by the very positive reaction from the medical community as well as from our commercial partners," said Phil Callow, Managing Director of SearchMedica. "Based on user surveys and feedback, we've decided to add further disease-focused custom search functionality so that our full range now includes All of Medicine, Cardiovascular, Diabetes/Endocrine, Infectious, Mental/Nervous System, Musculoskeletal, Cancer/Hemic, Pediatric and Respiratory. This extension is part of CMPMedica's ongoing strategy to widen the scope of the service to satisfy the information and workflow requirements of every major medical domain." , which was co-developed with Convera, is an advertising supported Web-based service that connects physicians and other medical professionals to credible, trusted and editorially approved medical Web sites, online journals and other clinical resources.

About CMPMedica

CMPMedica provides information and education to healthcare professionals and patients around the world. It has a unique portfolio of professional media products including newspapers, magazines, drug directories, electronic databases, websites and events.

About indexes only authoritative medical information, approved for inclusion by medical editors and a physician editorial board. Medical professionals receive more relevant, smaller sets of search results from than from mainstream engines, which contain consumer- oriented, paid testimonials and other types of unreliable information. Since is advertiser supported, medical professionals pay nothing to use the specialty search engine. All SearchMedica search results are independent and unbiased. They contain well-known, credible journals, peer- reviewed research, and evidence-based articles written for practicing healthcare professionals. SearchMedica is currently available at

About Convera(R)

Convera is the leading provider of search as a service for trade publishers and is the vertical search provider of choice for a growing number of specialist publishers around the world. Convera enables publishers to generate additional revenue by creating customized search applications for specialist audiences under their own brand and also manages the vertical search sites of a growing number of specialist publishers. Convera site search, vertical search and lead generation applications can combine publisher proprietary content with an editorially vetted best of the Web for specific professional audiences, providing an authoritative and comprehensive search experience. Many of the world's largest publishers are working with Convera to accelerate their e-publishing strategies, meet growing online revenue goals and build loyal online professional communities.

This release, including any statements from Convera personnel, contains statements about Convera's future expectations, performance, plans, and prospects, as well as assumptions about future events. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, business and economic conditions and trends; the ability to continue funding operating losses; fluctuations in operating results including impacts from reduced corporate IT spending and lengthier sales cycles; continued success in technological advances and development; possible disruption in commercial activities caused by terrorist activity and armed conflict, such as changes in logistics and security arrangements; reduced customer demand relative to expectations; competitive factors; and other risk factors listed from time to time in the company's reports to the Securities and Exchange Commission. Actual results may differ materially from our expectations as the result of these and other important factors relating to Convera's business and product development efforts, which are further described in Convera's filings with the SEC. These filings can be obtained from the SEC's website located at Any forward-looking statements are based on information available to Convera on the date of this release, and Convera assumes no obligation to update such statements. Convera(R) and the Convera design logo are trademarks of Convera in the United States and other countries.

SOURCE Convera
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nova Biosource Fuels Expands Senior Executive Team
2. Finesse Solutions Expands by Opening Sales and Service Centers
3. Evotec Expands Collaboration With InterMune
4. Novo Nordisk Expands U.S. Headquarters in New Jersey
5. Tunnell Consulting Expands Biotechnology Expertise
6. Progen Expands Board of Directors
7. BioVascular, Inc. Expands Executive Team
8. United BioSource Expands Regulatory Affairs Capabilities
9. Valensa Expands Astaxanthin Extraction Capacity
10. Progen Expands Drug Development Pipeline Through Acquisition of CellGate
11. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... 25, 2015 , ... Jessica Richman and Zachary Apte, founders ... initial angel funding process. Now, they are paying it forward to other microbiome ... investments in the microbiome space. In this, they join other successful entrepreneurs-turned-angels ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):